- Home
- PCRX vs PBT Comparison
PCRX vs PBT Comparison
Compare PCRX & PBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- PBT
- Stock Information
- Founded
- PCRX 2006
- PBT 1980
- Country
- PCRX United States
- PBT United States
- Employees
- PCRX N/A
- PBT N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- PBT Oil & Gas Production
- Sector
- PCRX Health Care
- PBT Energy
- Exchange
- PCRX Nasdaq
- PBT Nasdaq
- Market Cap
- PCRX 1.2B
- PBT 562.6M
- IPO Year
- PCRX 2011
- PBT N/A
- Fundamental
- Price
- PCRX $22.90
- PBT $12.94
- Analyst Decision
- PCRX Buy
- PBT
- Analyst Count
- PCRX 8
- PBT 0
- Target Price
- PCRX $28.38
- PBT N/A
- AVG Volume (30 Days)
- PCRX 545.0K
- PBT 151.7K
- Earning Date
- PCRX 07-29-2025
- PBT 01-01-0001
- Dividend Yield
- PCRX N/A
- PBT 4.21%
- EPS Growth
- PCRX N/A
- PBT N/A
- EPS
- PCRX N/A
- PBT 0.48
- Revenue
- PCRX $702,772,000.00
- PBT $24,140,674.00
- Revenue This Year
- PCRX $7.54
- PBT N/A
- Revenue Next Year
- PCRX $10.78
- PBT N/A
- P/E Ratio
- PCRX N/A
- PBT $26.51
- Revenue Growth
- PCRX 3.08
- PBT N/A
- 52 Week Low
- PCRX $11.16
- PBT $8.01
- 52 Week High
- PCRX $27.64
- PBT $14.26
- Technical
- Relative Strength Index (RSI)
- PCRX 35.82
- PBT 65.87
- Support Level
- PCRX $22.82
- PBT $12.66
- Resistance Level
- PCRX $23.83
- PBT $13.73
- Average True Range (ATR)
- PCRX 0.74
- PBT 0.38
- MACD
- PCRX -0.02
- PBT 0.00
- Stochastic Oscillator
- PCRX 6.22
- PBT 59.49
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About PBT Permian Basin Royalty Trust
Permian Basin Royalty Trust is an express trust. The company's underlying properties include Waddell Ranch Properties in which the trust holds mineral interest as well as royalty interests in mature producing oil fields, such as Yates, Wasson, Sand Hills, East Texas, Kelly-Snyder, Panhandle Regular, N. Cowden, Todd, Keystone, Kermit, McElroy, Howard-Glasscock, Seminole and others across Texas. The company earns majority revenue in form of royalties received through its properties.